Catalysts for Change: The Role of Nonprofits in Solving Single Ventricle Heart Disease
- PMID: 35877582
- PMCID: PMC9319216
- DOI: 10.3390/jcdd9070220
Catalysts for Change: The Role of Nonprofits in Solving Single Ventricle Heart Disease
Abstract
Single ventricle (SV) heart disease comprises a spectrum of complex congenital heart defects (CHDs), including hypoplastic left heart syndrome (HLHS), one of the most common causes of death amongst infants with CHD. Despite its incompletely defined etiology and a dearth of curative solutions, SV is a solvable problem that can be addressed by unifying a nascent field that is ripe for investment, in part due to its high economic impact and growth potential. Here, we explore the landscape of SV and identify areas of opportunity that will yield an outsized impact through strategic investment that focuses on synchronization across disciplines, community involvement, and infrastructure development, and argue that nonprofits are the appropriate catalyst to spark transformative innovation and impact in the form of functional cures.
Keywords: congenital heart disease; funding strategies; nonprofit; philanthropy; single ventricle.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Heaton J., Heller D. Consults in Obstetric Anesthesiology. Springer; Cham, Switzerland: 2021. Single Ventricle; pp. 535–536. - DOI
-
- Rychik J., Atz A.M., Celermajer D.S., Deal B.J., Gatzoulis M.A., Gewillig M.H., Hsia T.-Y., Hsu D.T., Kovacs A.H., McCrindle B.W., et al. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation. 2019;140:e234–e284. doi: 10.1161/CIR.0000000000000696. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources